Rare but lethal short QT syndrome: Most recent understanding of the disease

Mustafa Al Qaysi, Juan Simon Rico-Mesa, William Sovic, Manuel Endo-Carvajal, Auroa Badin

Producción científica: Review articlerevisión exhaustiva


Short QT syndrome (SQTS) is a rare genetic channelopathy that affects the repolarization of cardiac cells and is associated with cardiac arrhythmia and sudden cardiac death (SCD). “Abbreviated repolarization” is the hallmark of the disease, which is secondary to genetic defects; mutations in several genes that encode different cardiac ion channels have been identified in individuals with the disease. Presentations of the disease include syncope, atrial or ventricular arrhythmia and SCD. SQTS is diagnosed with a corrected-QT (QTc) interval of <340 milliseconds (ms) or a QTc of 340-360 ms and either personal or family history of SCD, family history of SQTS or an identified genetic mutation. Implantable cardioverter-defibrillator (ICD) is the main treatment used in the secondary prevention of SCD in patients with the disease who have experienced previous major arrhythmic events. Pharmacological treatment with quinidine is used as an adjuvant therapy to ICD in the setting of recurrent shocks or as an alternative treatment when ICD is not feasible. The goal of this review article is to describe this rare and under-studied condition, highlight steps to diagnosis and describe treatment modalities, particularly in South America where there is a lack of studies and understanding of this disease.

Idioma originalEnglish (US)
Número de artículoem154
PublicaciónElectronic Journal of General Medicine
EstadoPublished - 2019

ASJC Scopus subject areas

  • General Medicine


Profundice en los temas de investigación de 'Rare but lethal short QT syndrome: Most recent understanding of the disease'. En conjunto forman una huella única.

Citar esto